Metabolic syndrome and mammographic density in Mexican women

Cancer Prevention Research

Volumn 6, Issue 7, 2013, Pages 701-710

  Rice, Megan S ^a,b   Biessy, Carine ^c   Lajous, Martin ^a,d,e   Bertrand, Kimberly A ^a,b   Tamimi, Rulla M ^a,b   Torres Mejía, Gabriela ^d   López Ridaura, Ruy ^d   Romieu, Isabelle ^c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METABOLIC SYNDROME X; MEXICO; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; BREAST NEOPLASMS; COMPLICATION; CROSS-SECTIONAL STUDY; MAMMARY GLAND; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RISK FACTOR; YOUNG ADULT;

ADULT; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84880055973     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0475     Document Type: Article

References (25)

1. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9.
2. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007;86:s823-35.
3. Vona-Davis L, Howard-McNatt M, Rose DP. Adiposity, type 2 diabetes andthe metabolic syndromeinbreast cancer.ObesRev 2007;8:395-408.
4. Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol 2011;22:2687-92.
5. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in theORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 2010;20:41-8.
6. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010;19:1737-45.
7. Kabat GC, KimM, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2009;18:2046-53.
8. Conroy SM, Butler LM, Harvey D, Gold EB, Sternfeld B, Greendale GA, et al. Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer 2011;129:1699-707.
9. Rojas R, Aguilar-Salinas CA, Jimenez-Corona A, Shamah-Levy T, Rauda J, Avila-Burgos L, et al. Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010;52 SUPPL. 1:S11-8.
10. Romieu I, Lajous M. The role of obesity, physical activity and dietary factors on the risk for breast cancer: Mexican experience. Salud Publica Mex 2009;51 SUPPL. 2:S172-80.
11. Romieu I, Escamilla-Nunez MC, Sanchez-Zamorano LM, Lopez-Ridaura R, Torres-Mejia G, Yunes EM, et al. The association between body shape silhouette and dietary pattern amongMexicanwomen. Public Health Nutr 2011;15:116-25.
12. Martin LJ, Minkin S, Boyd NF. Hormone therapy, mammographic density, and breast cancer risk. Maturitas 2009;64:20-6.
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
14. Aschner P, Buendia R, Brajkovich I, Gonzalez A, Figueredo R, Juarez XE, et al. Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diabetes Res Clin Pract 2011;93:243-7.
15. Rojas-Martinez R, Aguilar-Salinas CA, Jimenez-Corona A. Optimal cutoff points for the detection of undiagnosed type 2 diabetes, hypertension and metabolic syndrome in Mexican adults. Salud Publica Mex 2012;54:13-9.
16. Torres-Mejia G, De Stavola B, Allen DS, Perez-Gavilan JJ, Ferreira JM, Fentiman IS, et al. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 2005;14:1052-9.
17. Bollen KA, Glanville JL, Stecklov G. Socioeconomic status and class in studies of fertility and health in developing countries. Annul Rev Sociol 2001;27:153-85.
18. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, et al. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14: 1411-7.
19. Sung J, Song YM, Stone J, Lee K, Kim SY. High-density lipoprotein cholesterol, obesity, and mammographic density in Korean women: the Healthy Twin study. J Epidemiol 2011;21:52-60.
20. Tamburrini AL, Woolcott CG, Boyd NF, Yaffe MJ, Terry T, Yasui Y, et al. Associations between mammographic density and serum and dietary cholesterol. Breast Cancer Res Treat 2011;125:181-9.
21. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
22. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, et al. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 2005;14:33-40.
23. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004;96:1152-60.
24. Porto LA, Lora KJ, Soares JC, Costa LO. Metabolic syndrome is an independent risk factor for breast cancer. Arch Gynecol Obstet 2011;284:1271-6.
25. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.